Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0254
+0.0012 (4.96%)
Aug 14, 2025, 11:28 AM CET
-97.46%
Market Cap 1.22M
Revenue (ttm) 3.00K
Net Income (ttm) 119.00K
Shares Out 50.38M
EPS (ttm) 0.09
PE Ratio 0.26
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 494,923
Average Volume 4,534,912
Open 0.0270
Previous Close 0.0242
Day's Range 0.0244 - 0.0270
52-Week Range 0.0230 - 2.0000
Beta 0.50
RSI 38.25
Earnings Date Sep 5, 2025

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.